Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Mayne Pharma Group Limited
  6. Financials
    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 10/22
0.345 AUD   +6.15%
10/19MAYNE PHARMA : 2021 Corporate Governance Statement and Appendix 4G
PU
10/07MITHRA PHARMACEUTICALS S A : Provides FDA Update on Myring
AQ
10/07MAYNE PHARMA : Provides fda update on generic nuvaringo
AQ
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Capitalization1 807646565609--
Entreprise Value (EV)1 1 088907814866864824
P/E ratio -2,68x-6,34x-2,41x-17,8x39,8x10,7x
Yield -----0,72%
Capitalization / Revenue 1,54x1,41x1,41x1,32x1,08x0,94x
EV / Revenue 2,07x1,98x2,03x1,88x1,53x1,27x
EV / EBITDA 8,31x9,51x12,8x14,2x7,10x4,45x
Price to Book 0,80x0,62x0,73x0,78x0,76x0,70x
Nbr of stocks (in thousands) 1 582 9371 679 0681 764 8411 764 841--
Reference price (AUD) 0,510,390,320,350,350,35
Announcement Date 08/22/201908/20/202008/26/2021---
1 AUD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net sales1 525457401461563650
EBITDA1 13195,363,560,9122185
Operating profit (EBIT)1 37,211,7-3,70-17,841,3106
Operating Margin 7,08%2,56%-0,92%-3,86%7,33%16,4%
Pre-Tax Profit (EBT)1 -354-135-264-44,513,996,1
Net income1 -281-92,8-208-26,714,258,7
Net margin -53,5%-20,3%-52,0%-5,79%2,53%9,03%
EPS2 -0,19-0,06-0,13-0,020,010,03
Dividend per Share2 -----0,00
Announcement Date 08/22/201908/20/202008/26/2021---
1 AUD in Million
2 AUD
Income Statement Evolution (Quarterly data)
Fiscal Period: June 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2
Net sales1 274251227230209192
EBITDA1 81,249,747,447,939,923,6
Operating profit (EBIT)1 19,60,50-12,324,02,30-6,00
Operating Margin 7,13%0,20%-5,41%10,4%1,10%-3,13%
Pre-Tax Profit (EBT)1 11,9-366-25,0-110-229-34,6
Net income1 2,60-283-17,5-75,3-181-27,1
Net margin 0,95%-113%-7,70%-32,8%-86,8%-14,1%
EPS2 0,00-0,19-0,01--0,12-0,02
Dividend per Share ------
Announcement Date 02/21/201908/22/201902/20/202008/20/202002/23/202108/26/2021
1 AUD in Million
2 AUD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net Debt1 280260249257255215
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,14x2,73x3,92x4,23x2,10x1,16x
Free Cash Flow1 94,743,941,811,728,088,1
ROE (Net Profit / Equities) 1,26%-1,25%-3,14%-1,65%4,45%10,2%
Shareholders' equity1 -22 2527 3976 6291 616319578
ROA (Net Profit / Asset) 0,81%-0,74%-1,73%0,20%2,93%6,40%
Assets1 -34 53012 52012 071-13 351485917
Book Value Per Share2 0,640,620,440,440,450,49
Cash Flow per Share2 0,070,060,040,020,040,07
Capex1 11,98,9917,130,735,641,4
Capex / Sales 2,27%1,97%4,26%6,65%6,32%6,36%
Announcement Date 08/22/201908/20/202008/26/2021---
1 AUD in Million
2 AUD
Key data
Capitalization (AUD) 608 870 061
Capitalization (USD) 454 923 835
Net sales (AUD) 400 800 000
Net sales (USD) 299 024 856
Number of employees 967
Sales / Employee (AUD) 414 478
Sales / Employee (USD) 309 229
Free-Float 77,2%
Free-Float capitalization (AUD) 470 074 347
Free-Float capitalization (USD) 351 221 120
Avg. Exchange 20 sessions (AUD) 1 391 355
Avg. Exchange 20 sessions (USD) 1 038 048
Average Daily Capital Traded 0,23%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA